Working on issues regarding injectable and biologic medications.
Issues related to the naming of biosimilars as they enter into the national prescription drug marketplace. Working to ensure that issues related to coding and reimbursement are discussed and addressed to ensure a smooth start to the coverage of biosimilar medications as they enter into the United States' prescription drug market this year.
PHA - Pharmacy MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
NATHANSON+HAUCK
601 13th Street NW, Suite 290 North, Washington, DC, 20005, US
MELANIE JAN NATHANSON MEGAN HAUCK MARSHALL MELANIE JAN NATHANSON MEGAN HAUCK MARSHALL